ITGAM and neoplasm: However, although the PD-L1 expression on the tumor CD11b+F4/80+ macrophages was found to be decreased in the combination treatment compared to the Mit-A alone, no significant changes were observed when compared to the αPD-L1 mAb monotherapy (Figure 5H).